Use of Unbound Drug Concentration in Blood to Discriminate Between Two Models of Hepatic Drug Elimination
- 1 May 1982
- journal article
- website
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 71 (5) , 600-602
- https://doi.org/10.1002/jps.2600710536
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- A METHOD OF DETERMINING INTRINSIC HEPATIC CLEARANCE FROM THE FIRST-PASS EFFECTClinical and Experimental Pharmacology and Physiology, 1980
- Enhanced Bioavailability and Decreased Clearance of Analgesics in Patients with CirrhosisGastroenterology, 1979
- Current models of hepatic eliminationGastroenterology, 1979
- Hepatic clearance of drugs. II. Experimental evidence for acceptance of the “well-stirred” model over the “parallel tube” model using lidocaine in the perfused rat liverin situ preparationJournal of Pharmacokinetics and Biopharmaceutics, 1977
- Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearanceJournal of Pharmacokinetics and Biopharmaceutics, 1977
- Altered Hepatic Blood Flow and Drug Disposition1Clinical Pharmacokinetics, 1976
- Clearance concepts in pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1973